STARBUCKS CORP (SBUX)       104.3  -4.85 (-4.44%)

104.3  -4.85 (-4.44%)

US8552441094 - Common Stock - After market: 104.21 -0.09 (-0.09%)


Fundamental Rating

4

Overall SBUX gets a fundamental rating of 4 out of 10. We evaluated SBUX against 142 industry peers in the Hotels, Restaurants & Leisure industry. SBUX has a medium financial health rating, its profitability is only medium as well. While showing a medium growth rate, SBUX is valued expensive at the moment.




Profitability

Profitability Rating

4

SBUX has a Return On Assets of 11.73%. This is amongst the best returns in the industry. The industry average is 6.32%. SBUX outperforms 82% of its industry peers.
SBUX has a Profit Margin of 10.18%. This is comparable to the industry average of 10.02%.

SBUX has a Piotroski-F score of 5.00. This indicates an average health and profitability for SBUX.
VS Industry

ROA (11.73%) VS Industry: 82% outperformed.

0.25
59.88

Profit Margin (10.18%) VS Industry: 52% outperformed.

0.39
31,293.41

Valuation

Valuation Rating

0

With a Price/Earnings Ratio of 35.24, SBUX can be considered very expensive at the moment.
Compared to an average industry Price/Earning Ratio of 21.41, SBUX is valued more expensive than its industry peers. On top of this 82% of the companies listed in the same industry are cheaper than SBUX!
With a Forward Price/Earnings Ratio of 29.98, SBUX is valued very expensively.

The high PEG Ratio, which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
Compared to an average industry Enterprise Value to EBITDA ratio of 13.78, SBUX is valued more expensive than its industry peers. 80% of the companies listed in the same industry are valued cheaper.
VS Industry

Price/Earnings (35.24) VS Industry: 18% outperformed.

277.57
1.73

Enterprise Value/ EBITDA (22.92) VS Industry: 20% outperformed.

205.04
3.24

Growth

Growth Rating

6

Based on estimates for the next 5 years, SBUX will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.84% on average per year.
When comparing the EPS growth rate of the last 5 years to the growth rate of the upcoming 5 years, we see that the growth is accelerating.
SBUX shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 10.98%.
SBUX is expected to show quite a strong growth in Revenue. In the coming 5 years, the Revenue will grow by 11.61% yearly.

When comparing the Revenue growth rate of the last 5 years to the growth rate of the upcoming 5 years, we see that the growth is accelerating.
SBUX shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -8.64%.
Measured over the past 5 years, SBUX shows a small growth in Earnings Per Share. The EPS has been growing by 7.41% on average per year.
The Revenue has been growing slightly by 7.57% on average over the past 5 years.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS7.41% 2.36% -8.64% 17.52% 17.71% 17.78% 18.84%
Revenue7.57% 6.75% 10.98% 11.61% 11.28% 10.93% 11.61%

Health

Health Rating

4

An Altman-Z score of 3.21 indicates that SBUX is not in any danger for bankruptcy at the moment.
The Altman-Z score of SBUX is much better than the industry average of 1.44. SBUX has a better rating than 84% of its industry peers.
SBUX has a Piotroski-F score of 5.00. This indicates an average health and profitability for SBUX.
A Current Ratio of 0.77 indicates that SBUX may have some problems paying its short term obligations.

Compared to an average industry Current Ratio of 1.09, SBUX is worse placed to pay its short term obligations than its industry peers.
A Quick Ratio of 0.53 indicates that SBUX may have some problems paying its short term obligations.
When comparing the Quick Ratio of SBUX to the average industry Current Ratio of 1.01, SBUX is less able to pay its short term obligations than its industry peers.
VS Industry

Quick Ratio (0.53) VS Industry: 21% outperformed.

0.03
17.41

Current Ratio (0.77) VS Industry: 33% outperformed.

0.03
17.41

Altman-Z (3.21) VS Industry: 84% outperformed.

-28.23
58.85

Dividend

Dividend Rating

6

The dividend of SBUX is nicely growing with an annual growth rate of 10.82%!
The dividend of SBUX is growing, but earnings are growing more, so the dividend growth is sustainable.
SBUX has paid a dividend for at least 10 years, which is a reliable track record.
SBUX has a Yearly Dividend Yield of 2.02%. Purely for dividend investing, there may be better candidates out there.

SBUX's Dividend Yield is comparable with the industry average which is at 2.09.
Compared to an average S&P500 Dividend Yield of 2.41, SBUX has a dividend comparable with the average S&P500 company.
68.97% of the earnings are spent on dividend by SBUX. This is not a sustainable payout ratio.
VS Industry

Dividend Yield (2.02%) VS Industry: 45% outperformed.

0.03
8.60

STARBUCKS CORP104.3

NASDAQ:SBUX (2/3/2023, 7:06:52 PM)-4.85 (-4.44%)

After market: 104.21 -0.09 (-0.09%)

Chartmill FA Rating
GICS Sector Consumer Discretionary
GICS IndustryGroup Consumer Services
GICS Industry Hotels, Restaurants & Leisure
Earnings (Last) 02-03 2023-02-03/amc Earnings (Next) 05-02 2023-05-02/amc
Inst Owners 71.57% Inst Owner Change 1.17%
Ins Owners 1.84% Ins Owner Change 0.9%
Market Cap 119.72B Analysts 72.09
Price Target 103.15 (-1.1%)

Dividend
Industry RankSector Rank
Dividend Yield 2.02%
Dividend Growth(5Y) 10.82% DP 68.97%
Div Incr Years 12 Div Non Decr Years 12
Ex-Date 02-09 2023-02-09 (0.53)

Surprises & Revisions
EPS beat(2) 2 Avg EPS beat(2) 9.69%
Min EPS beat(2) 9.39% Max EPS beat(2) 9.99%
EPS beat(4) 2 Avg EPS beat(4) 1.37%
Min EPS beat(4) -11.39% Max EPS beat(4) 9.99%
Revenue beat(2) N/A Avg Revenue beat(2) -1.08%
Min Revenue beat(2) -1.41% Max Revenue beat(2) -0.75%
Revenue beat(4) N/A Avg Revenue beat(4) -1.08%
Min Revenue beat(4) -1.41% Max Revenue beat(4) -0.75%
PT rev (1m) 1.63% PT rev (3m) 4.57%
EPS NQ rev (1m) N/A EPS NQ rev (3m) N/A
EPS NY rev (1m) 0% EPS NY rev (3m) 1.65%
Revenue NQ rev (1m) N/A Revenue NQ rev (3m) N/A
Revenue NY rev (1m) 0% Revenue NY rev (3m) -0.14%

Valuation
Industry RankSector Rank
PE 35.24
Fwd PE 29.98
P/S 3.71
P/FCF 46.84
P/OCF 27.22
P/B N/A
P/tB N/A
EV/EBITDA 22.92
EPS(TTM) 2.96 EY 2.84%
EPS(NY) 3.48 Fwd EY 3.34%
FCF(TTM) 2.23 FCFY 2.14%
OCF(TTM) 3.83 OCFY 3.67%
SpS 28.1 BVpS -7.59
TBVpS -10.58 PEG (NY) 2.01
PEG (5Y) 4.75

Profitability
Industry RankSector Rank
ROA 11.73%
ROE N/A
ROIC 18.18%
ROICexc 21.84%
ROICexgc 27.91%
OM 13.74%
PM 10.18%
GM 25.96%
ROICexgc(3y) 22.08% ROICexcg growth 3Y -17.85%
ROICexcg growth 5Y -12.72% ROICexc(3y) 16.99%
ROICexc growth 3Y -9.48% ROICexc growth 5Y -11.61%
OM growth 3Y -2.15% OM growth 5Y -4.49%
PM growth 3Y -9.16% PM growth 5Y -4.61%
GM growth 3Y -2.72% GM growth 5Y -3.22%
F-Score 5 Asset Turnover 1.15

Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 5.89
Debt/EBITDA 2.52
Cap/Depr 120.39%
Profit Quality 77.89%
Current Ratio 0.77
Quick Ratio 0.53
Altman-Z 3.21
F-Score 5 WACC 9.24%
ROIC/WACC 3.02 Cap/Depr(3y) 105.19%
Cap/Depr(5y) 118.32% Profit Quality(3y) 65.93%
Profit Quality(5y) 101.66%

Growth
EPS 1Y -8.64% EPS 3Y 2.36%
EPS 5Y 7.41% EPS growth Q2Q -19%
EPS Next Y 17.52% EPS Next 2Y 17.71%
EPS Next 3Y 17.78% EPS Next 5Y 18.84%
Revenue growth 1Y 10.98% Revenue growth 3Y 6.75%
Revenue growth 5Y 7.57% Revenue growth Q2Q 3.28%
Revenue Next Year 11.61% Revenue Next 2Y 11.28%
Revenue Next 3Y 10.93% Revenue Next 5Y 11.61%
EBIT growth 1Y -4.89% EBIT growth 3Y 4.46%
EBIT growth 5Y 2.75% EBIT Next Year 48.64%
EBIT Next 3Y 24.32% EBIT Next 5Y 20.94%
FCF growth 1Y -43.44% FCF growth 3Y -7.6%
FCF growth 5Y -0.76% OCF growth 1Y -26.58%
OCF growth 3Y -4.49% OCF growth 5Y 1.05%

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA